Launxp Biomedical Co Stock

Launxp Biomedical Co Net Margin

The Net Profit Margin of Launxp Biomedical Co (6876.TWO) as of Aug 1, 2026 is -3,325.08 %. In the previous year, Net Profit Margin was -735,900.00 % — a change of -99.55% (higher).

Net Margin

-3,325.08 %

YoY

-99.55%

Last updated:

Net Profit Margin of Launxp Biomedical Co is 2026 -3,325.08 % . Net Profit Margin of Launxp Biomedical Co was 2025 -735,900.00 % . It decreases by -99.55% higher compared to the previous year.

Launxp Biomedical Co's net margin stands at -3,325.1%, up from -3,594.6% several years earlier.

Access this data via the Eulerpool API

Launxp Biomedical Co Stock analysis

What does Launxp Biomedical Co do? Launxp Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Launxp Biomedical Co stock

Net Profit Margin of Launxp Biomedical Co is -3,325.08 % in 2026.

Access this data via the Eulerpool API

Margins — Launxp Biomedical Co

All Key Metrics — Launxp Biomedical Co